---
title: "康沣生物科技(上海)股份有限公司 (06922.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/06922.HK.md"
symbol: "06922.HK"
name: "康沣生物科技(上海)股份有限公司"
industry: "医疗器械"
---

# 康沣生物科技(上海)股份有限公司 (06922.HK)

| Item | Detail |
|------|--------|
| Industry | 医疗器械 |
| Location | 港股市场 |
| Website | [www.cryofocus.com](https://www.cryofocus.com) |

## Company Profile

我们是一家中国创新医疗器械公司，主要专注于微创介入冷冻治疗领域。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: C (0.51)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 21 / 26 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 105.47% |  |
| Net Profit YoY | 28.36% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 22.89 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.44B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 92.35M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -86.70% | E |
| Profit Margin | -89.25% | E |
| Gross Margin | 67.14% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 105.47% | A |
| Net Profit YoY | 28.36% | B |
| Total Assets YoY | -11.85% | E |
| Net Assets YoY | -52.15% | E |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -112.04% | D |
| OCF YoY | 105.47% | A |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.49 | C |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 62.95% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 康沣生物科技(上海)股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-86.70%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-89.25%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "67.14%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "105.47%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "28.36%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-11.85%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-52.15%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-112.04%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "105.47%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.49",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "62.95%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 时代天使 (HK.6699) | B | A | C | B | B | B |
| 02 | 归创通桥 (HK.2190) | B | A | D | A | B | B |
| 03 | 爱康医疗 (HK.1789) | B | A | C | B | B | B |
| 04 | 心泰医疗 (HK.2291) | A | B | D | A | B | B |
| 05 | 现代牙科 (HK.3600) | A | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -17.32 | 24/27 | - | - | - |
| PB | 22.89 | 26/27 | 24.52 | 20.81 | 14.54 |
| PS (TTM) | 15.46 | 21/27 | 20.93 | 17.13 | 15.46 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-07-24T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.90 |

## References

- [Company Overview](https://longbridge.com/en/quote/06922.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/06922.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/06922.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.